FDA — authorised 16 April 2004
- Application: BLA021629
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: supplemented
FDA authorised Apidra on 16 April 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 April 2004; FDA has authorised it.
SANOFI AVENTIS US holds the US marketing authorisation.